Systemic Right Ventricle Long-term Outcome (SINCERE)
Systemic Right Ventricle Long-term Outcome: a Multicentre Study
Sponsor: Hartekind
Listed as NCT06258083, this observational or N/A phase trial focuses on Systemic Right Ventricle and Transposition of the Great Arteries and remains completed. Sponsored by Hartekind, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2024 — Jul 2024 [monthly]
Completed
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hartekind
- Hartstichting
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .